Skip to main content
Top
Published in: BMC Gastroenterology 1/2020

Open Access 01-12-2020 | Histamine H2-Receptor Antagonist | Research article

Investigation of the clinical significance and pathological features of lanthanum deposition in the gastric mucosa

Authors: Shinya Nishida, Kazuhiro Ota, Kimiaki Hattori, Taro Iwatsubo, Shimpei Kawaguchi, Yuichi Kojima, Toshihisa Takeuchi, Tamaki Maeda, Masahiro Sakaguchi, Kazuhide Higuchi

Published in: BMC Gastroenterology | Issue 1/2020

Login to get access

Abstract

Background

There are often specific endoscopic findings caused by deposition of lanthanum (La) in the gastric mucosa of patients taking lanthanum carbonate (LaC), a novel phosphate binder for patients on hemodialysis. We conducted a retrospective study to investigate the clinical significance of La deposition in the gastric mucosa, and the association between endoscopic features and histologic findings in the same population.

Methods

We compared background factors in patients taking LaC with and without La deposition in their gastroscopic biopsy specimen. We also investigated the relationship between gastric endoscopic biopsy specimens with La deposition and the concurrent endoscopic images.

Results

There was a significant difference in the total dose of LaC between the La-positive and La-negative groups (990 g [180–3150 g] vs. 480 g [225–1328 g]; p = 0.013). In 27 biopsy specimens with specific whitish mucosa, 10 showed mild histiocytic infiltration and 17 showed severe infiltration. In contrast, among 24 specimens with non-whitish mucosa, 5 showed no histiocytic infiltration, 10 showed mild infiltration, and 9 showed severe infiltration. There was a significant relationship between endoscopic features and the degree of histiocytic infiltration (p = 0.026).

Conclusions

We demonstrated that La deposition in the gastric mucosa depended on the total dose of LaC and was not affected by background factors. The specific endoscopic features of La deposition are associated with the infiltration of histiocytes, which represents the body’s normal response to foreign bodies.
Trial registry The protocol was registered in the University Hospital Medical Information Network Clinical Trial Registry (UMIN000038929, https://​upload.​umin.​ac.​jp/​cgi-open-bin/​ctr/​ctr_​view.​cgi?​recptno=​R000044393).
Literature
1.
go back to reference Masakane I, Taniguchi M, Nakai S, et al. Annual dialysis data report 2016, JSDT Renal Data Registry. Ren Replace Ther. 2018;4:45.CrossRef Masakane I, Taniguchi M, Nakai S, et al. Annual dialysis data report 2016, JSDT Renal Data Registry. Ren Replace Ther. 2018;4:45.CrossRef
2.
go back to reference Makino M, Kawaguchi K, Shimojo H, et al. Extensive lanthanum deposition in the gastric mucosa: the first histopathological report. Pathol Int. 2015;65:33–7.CrossRef Makino M, Kawaguchi K, Shimojo H, et al. Extensive lanthanum deposition in the gastric mucosa: the first histopathological report. Pathol Int. 2015;65:33–7.CrossRef
3.
go back to reference Hattori K, Maeda T, Nishida S, et al. Correlation of lanthanum dosage with lanthanum deposition in the gastroduodenal mucosa of dialysis patients. Pathol Int. 2017;67:447–52.CrossRef Hattori K, Maeda T, Nishida S, et al. Correlation of lanthanum dosage with lanthanum deposition in the gastroduodenal mucosa of dialysis patients. Pathol Int. 2017;67:447–52.CrossRef
4.
go back to reference Ozaki H, Ota K, Kojima Y, et al. Small intestinal lesions in patients with anemia on hemodialysis: a two-center, cross-sectional study. Digestion. 2019;101:730–6.CrossRef Ozaki H, Ota K, Kojima Y, et al. Small intestinal lesions in patients with anemia on hemodialysis: a two-center, cross-sectional study. Digestion. 2019;101:730–6.CrossRef
5.
go back to reference Shitomi Y, Nishida H, Kusaba T, et al. Gastric lanthanosis (lanthanum deposition) in dialysis patients treated with lanthanum carbonate. Pathol Int. 2017;67:389–97.CrossRef Shitomi Y, Nishida H, Kusaba T, et al. Gastric lanthanosis (lanthanum deposition) in dialysis patients treated with lanthanum carbonate. Pathol Int. 2017;67:389–97.CrossRef
6.
go back to reference Ban S, Suzuki S, Kubota K, et al. Gastric mucosal status susceptible to lanthanum deposition in patients treated with dialysis and lanthanum carbonate. Ann Diagn Pathol. 2017;26:6–9.CrossRef Ban S, Suzuki S, Kubota K, et al. Gastric mucosal status susceptible to lanthanum deposition in patients treated with dialysis and lanthanum carbonate. Ann Diagn Pathol. 2017;26:6–9.CrossRef
7.
go back to reference Iwamuro M, Urata H, Okada H. Relationship between gastric lanthanum deposition and Helicobacter pylori-associated chronic gastritis: is it rare or common? Pathol Int. 2017;67:649.CrossRef Iwamuro M, Urata H, Okada H. Relationship between gastric lanthanum deposition and Helicobacter pylori-associated chronic gastritis: is it rare or common? Pathol Int. 2017;67:649.CrossRef
8.
go back to reference Iwamuro M, Tanaka T, Urata H, et al. Lanthanum phosphate deposition in the duodenum. Gastrointest Endosc. 2017;85:1103–4.CrossRef Iwamuro M, Tanaka T, Urata H, et al. Lanthanum phosphate deposition in the duodenum. Gastrointest Endosc. 2017;85:1103–4.CrossRef
9.
go back to reference Murakami N, Yoshioka M, Iwamuro M, et al. Clinical characteristics of seven patients with lanthanum phosphate deposition in the stomach. Intern Med. 2017;56:2089–95.CrossRef Murakami N, Yoshioka M, Iwamuro M, et al. Clinical characteristics of seven patients with lanthanum phosphate deposition in the stomach. Intern Med. 2017;56:2089–95.CrossRef
10.
go back to reference Moayyedi P. The health economics of Helicobacter pylori infection. Best Pract Res Clin Gastroenterol. 2007;21:347–61.CrossRef Moayyedi P. The health economics of Helicobacter pylori infection. Best Pract Res Clin Gastroenterol. 2007;21:347–61.CrossRef
11.
go back to reference Damment SJ, Pennick M. Clinical pharmacokinetics of the phosphate binder lanthanum carbonate. Clin Pharmacokinet. 2008;47:553–63.CrossRef Damment SJ, Pennick M. Clinical pharmacokinetics of the phosphate binder lanthanum carbonate. Clin Pharmacokinet. 2008;47:553–63.CrossRef
12.
go back to reference Hutchison AJ, Wilson RJ, Garafola S, et al. Lanthanum carbonate: safety data after 10 years. Nephrology (Carlton). 2016;21:987–94.CrossRef Hutchison AJ, Wilson RJ, Garafola S, et al. Lanthanum carbonate: safety data after 10 years. Nephrology (Carlton). 2016;21:987–94.CrossRef
13.
go back to reference Kimura K, Takemoto T. An endoscopic recognition of the atrophic border and its significance in chronic gastritis. Endoscopy. 1969;1:87–97.CrossRef Kimura K, Takemoto T. An endoscopic recognition of the atrophic border and its significance in chronic gastritis. Endoscopy. 1969;1:87–97.CrossRef
Metadata
Title
Investigation of the clinical significance and pathological features of lanthanum deposition in the gastric mucosa
Authors
Shinya Nishida
Kazuhiro Ota
Kimiaki Hattori
Taro Iwatsubo
Shimpei Kawaguchi
Yuichi Kojima
Toshihisa Takeuchi
Tamaki Maeda
Masahiro Sakaguchi
Kazuhide Higuchi
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Gastroenterology / Issue 1/2020
Electronic ISSN: 1471-230X
DOI
https://doi.org/10.1186/s12876-020-01545-z

Other articles of this Issue 1/2020

BMC Gastroenterology 1/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine